ISPOR - HPR22 Does Expedited Regulatory Approval Status Increase Rare Disease Drug Non-Coverage?

Full Text

HPR22 Does Expedited Regulatory Approval Status Increase Rare Disease Drug Non-Coverage?

Abstract

Authors

M Fraser K Clifton B Privett

Back to Volume 27, Supplemental Issue 6S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now